July 7, 2022
Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mariluz Alejo as Director of Quality
Thursday, July 7th, 2022PRESS RELEASE Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality Winnipeg, MB – July 7th, 2022 – Cubresa Inc., a world leader in the design and development of PET insert systems for brain imaging, is announcing two new senior appointments: Mr. Matt Hudson…
June 20, 2022
DOTMed HealthCare magazine features Cubresa
Cubresa is pleased to have its clinical BrainPET insert system and preclinical NuPET Bio scanner, designed for use in infectious disease research, featured on page 44 in the June 2022 issue of DOTMed’s HealthCare Business News magazine. DOTMed HealthCare link The BrainPET is an investigational device and NOT AVAILABLE FOR COMMERCIAL SALE.
May 2, 2022
Lawson Health Research Institute selects Cubresa’s BrainPET system to support neurological research studies
Monday, May 2nd, 2022 PRESS RELEASE Lawson Health Research Institute selects Cubresa’s BrainPET system to support neurological research studies Winnipeg, MB – May 2nd, 2022 – Lawson Health Research Institute has selected Cubresa’s investigational BrainPET system to add to their suite of imaging tools. The BrainPET scanner will be used to support neurological research studies…
April 29, 2022
Brain & Brain PET 2022
Cubresa Inc. will take part in Brain & Brain PET in Glasgow, Scotland from May 29th to June 1st. Please join us at the technical exhibition. See you at @Brain2022!
April 29, 2022
ISMRM 2022
Cubresa Inc. is pleased to participate in ISMRM 2022 from May 8th to 12th in London, England. Please join us at the technical exhibition at booth D22. We look forward to seeing you in London!
Cubresa Appoints Ms. Leah Friesen as Director of Operations
Tuesday, April 5th, 2022 PRESS RELEASE Cubresa Appoints Ms. Leah Friesen as Director of Operations Winnipeg, MB – April 5th, 2022 – Cubresa Inc., a world leader in the design and development of PET insert systems for MRI, is announcing a new senior appointment within the company, Ms. Leah Friesen as the Director of Operations. “Cubresa’s…
Case Western Reserve University selects Cubresa’s NuPET™ System to Support Preclinical Research Activities
Wednesday, February 16th, 2022 PRESS RELEASE Case Western Reserve University selects Cubresa’s NuPET™ System to Support Preclinical Research Activities Winnipeg, MB – February 16th, 2022 – Case Western Reserve University (CWRU) has selected Cubresa’s Preclinical NuPET™ Insert System to add to their suite of imaging tools. The NuPET 66 will support research in a wide…
Barrow Neurological Institute selects Cubresa’s BrainPET system to support neurological research activities
Barrow Neurological Institute selects Cubresa’s BrainPET system to support neurological research activities Winnipeg, MB – January 5th, 2022 – Barrow Neurological Institute, the world’s largest neurological disease treatment and research institution, in conjunction with Arizona State University (ASU), have selected Cubresa’s BrainPET system to add to their suite of imaging tools. A joint acquisition between Barrow…
Recognizing Dr. Sheryl Herrera
Cubresa is pleased to recognize the work of our colleague, Dr. Sheryl Herrera, who has been recently published in ScienceDirect – Axon diameter inferences in the human corpus callosum using oscillating gradient spin echo sequences – link here – https://www.sciencedirect.com/science/article/abs/pii/S0730725X21001818#ab0005 . University of Winnipeg article here – https://news.uwinnipeg.ca/researchers-develop-new-way-to-measure-human-brain/
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Company
About Us
Leadership
Technology
Careers
Location
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4